EUVIMEDEUVIMED entdecken
Crossref

Development of TSHR-CAR NK-92 cells for Differentiated Thyroid Cancer

Jiahui Zhou, Chengcheng Zhang, Weibo Mao, Yiling Zhu, Huan Zhao, Ruozhen Han, You Peng, Gang Pan, Yang Fang

Molecular and Cellular Endocrinology · 2024-08 · 589 · 112251

DOI: 10.1016/j.mce.2024.112251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024-08. Verfasst von Jiahui Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, LiShui Central Hospital, The Fifth Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, China. Hauptthemen laut MEDLINE: Receptors, Thyrotropin, Thyroid Neoplasms, Killer Cells, Natural, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ThyrotropinThyroid NeoplasmsKiller Cells, NaturalReceptors, Chimeric AntigenHumansAnimalsCell Line, TumorMiceCell DifferentiationXenograft Model Antitumor AssaysMice, Inbred NODCell ProliferationCytotoxicity, ImmunologicImmunotherapy, Adoptive

Stichwörter der Autor:innen

Differentiated thyroid cancerNK cellTSHR-CARTumor treatment

Substanzen

Receptors, ThyrotropinReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Pathology, LiShui Central Hospital, The Fifth Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, China.
  • Core Facilities, Zhejiang University School of Medicine, Zhejiang Province, China.
  • Radiotherapy Center, Wenzhou Central Hospital, Zhejiang Province, China.
  • Department of Surgical Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Zhejiang Province, China. Electronic address: doctor3663@163.com.
  • Department of Surgical Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Zhejiang Province, China. Electronic address: xjxsh@163.com.
  • Department of Surgical Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Zhejiang Province, China. Electronic address: bravefang@163.com.

Zitieren

APA

Zhou, J., Zhang, C., Mao, W., Zhu, Y., Zhao, H., Han, R., Peng, Y., Pan, G., & Fang, Y. (2024). Development of TSHR-CAR NK-92 cells for Differentiated Thyroid Cancer. Molecular and Cellular Endocrinology, 589, 112251. https://doi.org/10.1016/j.mce.2024.112251

Vancouver

Zhou J, Zhang C, Mao W, Zhu Y, Zhao H, Han R, et al. Development of TSHR-CAR NK-92 cells for Differentiated Thyroid Cancer. Molecular and Cellular Endocrinology. 2024;589:112251. doi:10.1016/j.mce.2024.112251

BibTeX
@article{Zhou2024,
  author = {Zhou, Jiahui and Zhang, Chengcheng and Mao, Weibo and Zhu, Yiling and Zhao, Huan and Han, Ruozhen and Peng, You and Pan, Gang and Fang, Yang},
  title = {Development of TSHR-CAR NK-92 cells for Differentiated Thyroid Cancer},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  volume = {589},
  pages = {112251},
  doi = {10.1016/j.mce.2024.112251}
}
Kostenlos starten →